News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,383 Results
Type
Article (87421)
Company Profile (739)
Press Release (770205)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (232770)
Career Advice (4143)
Deals (39874)
Drug Delivery (144)
Drug Development (91179)
Employer Resources (205)
FDA (18255)
Job Trends (17422)
News (396860)
Policy (39846)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3002)
Academic (1)
Accelerated approval (31)
Adcomms (30)
Allergies (120)
Alliances (56795)
ALS (154)
Alzheimer's disease (1751)
Antibody-drug conjugate (ADC) (312)
Approvals (18371)
Artificial intelligence (469)
Autoimmune disease (160)
Automation (31)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (457)
Bladder cancer (145)
Brain cancer (52)
Breast cancer (539)
Cancer (4283)
Cardiovascular disease (301)
Career advice (3568)
Career pathing (41)
CAR-T (291)
CDC (37)
Celiac Disease (1)
Cell therapy (764)
Cervical cancer (29)
Clinical research (76116)
Collaboration (1609)
Company closure (4)
Compensation (998)
Complete response letters (64)
COVID-19 (2927)
CRISPR (85)
C-suite (737)
Cystic fibrosis (143)
Data (5420)
Decentralized trials (2)
Denatured (73)
Depression (114)
Diabetes (342)
Diagnostics (6977)
Digital health (23)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (252)
Drug pricing (161)
Drug shortages (19)
Duchenne muscular dystrophy (201)
Earnings (98004)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (132821)
Executive appointments (825)
FDA (20633)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1272)
Gene editing (183)
Generative AI (46)
Gene therapy (606)
GLP-1 (931)
Government (5326)
Grass and pollen (4)
Guidances (276)
Healthcare (20778)
HIV (43)
Huntington's disease (46)
IgA nephropathy (79)
Immunology and inflammation (267)
Immuno-oncology (59)
Indications (81)
Infectious disease (3147)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (95)
Intellectual property (198)
Interviews (816)
IPO (17809)
IRA (45)
Job creations (5198)
Job search strategy (2866)
JPM (66)
Kidney cancer (16)
Labor market (92)
Layoffs (639)
Leadership (37)
Legal (10091)
Liver cancer (87)
Longevity (13)
Lung cancer (585)
Lymphoma (331)
Machine learning (41)
Management (66)
Manufacturing (715)
MASH (159)
Medical device (14424)
Medtech (14454)
Mergers & acquisitions (22745)
Metabolic disorders (1066)
Multiple sclerosis (154)
NASH (22)
Neurodegenerative disease (330)
Neuropsychiatric disorders (79)
Neuroscience (2900)
Neurotech (1)
NextGen: Class of 2026 (7686)
Non-profit (5080)
Now hiring (65)
Obesity (522)
Opinion (326)
Ovarian cancer (150)
Pain (153)
Pancreatic cancer (170)
Parkinson's disease (260)
Partnered (33)
Patents (396)
Patient recruitment (419)
Peanut (56)
People (66285)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase 1 (23598)
Phase 2 (33126)
Phase 3 (24817)
Pipeline (4313)
Policy (283)
Postmarket research (3544)
Preclinical (10586)
Press Release (72)
Prostate cancer (203)
Psychedelics (51)
Radiopharmaceuticals (278)
Rare diseases (797)
Real estate (7423)
Recruiting (80)
Regulatory (28245)
Reports (63)
Research institute (2695)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (63)
Schizophrenia (139)
Series A (225)
Series B (161)
Service/supplier (25)
Sickle cell disease (85)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4323)
State (2)
Stomach cancer (14)
Supply chain (74)
Tariffs (76)
The Weekly (122)
Vaccines (999)
Venture capital (91)
Weight loss (339)
Women's health (72)
Worklife (22)
Date
Today (80)
Last 7 days (448)
Last 30 days (1678)
Last 365 days (25327)
2026 (2459)
2025 (25560)
2024 (34046)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (85)
Alaska (6)
Arizona (288)
Arkansas (8)
Asia (51126)
Australia (9003)
California (9738)
Canada (2480)
China (1059)
Colorado (306)
Connecticut (390)
Delaware (295)
Europe (116918)
Florida (1259)
Georgia (253)
Hawaii (4)
Idaho (65)
Illinois (652)
India (56)
Indiana (447)
Iowa (21)
Japan (341)
Kansas (133)
Kentucky (25)
Louisiana (15)
Maine (59)
Maryland (1257)
Massachusetts (7323)
Michigan (244)
Minnesota (455)
Mississippi (5)
Missouri (79)
Montana (28)
Nebraska (29)
Nevada (106)
New Hampshire (57)
New Jersey (2554)
New Mexico (29)
New York (2557)
North Carolina (1412)
North Dakota (9)
Northern California (4781)
Ohio (257)
Oklahoma (18)
Oregon (51)
Pennsylvania (1875)
Puerto Rico (22)
Rhode Island (33)
South America (1658)
South Carolina (13)
South Dakota (1)
Southern California (3757)
Tennessee (59)
Texas (1366)
United States (33855)
Utah (209)
Vermont (1)
Virginia (168)
Washington D.C. (55)
Washington State (818)
West Virginia (2)
Wisconsin (83)
858,383 Results for "passage bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
November 5, 2025
·
1 min read
Press Releases
Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights
November 10, 2025
·
10 min read
Press Releases
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
October 15, 2025
·
1 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
August 29, 2025
·
1 min read
Press Releases
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights
August 12, 2025
·
10 min read
Press Releases
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
June 23, 2025
·
8 min read
Press Releases
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
May 14, 2025
·
8 min read
Press Releases
Passage Bio to Participate in Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
Press Releases
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
February 5, 2026
·
8 min read
1 of 85,839
Next
